Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study) : A Multicenter Nationwide Study
© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..
CONTEXT: The aims of the study are to compare characteristics of subacute thyroiditis (SAT) related to different etiologies, and to identify predictors of recurrence of SAT and incident hypothyroidism.
METHODS: This nationwide, multicenter, retrospective cohort study included 53 endocrinology centers in Turkey. The study participants were divided into either COVID-19-related SAT (Cov-SAT), SARS-CoV-2 vaccine-related SAT (Vac-SAT), or control SAT (Cont-SAT) groups.
RESULTS: Of the 811 patients, 258 (31.8%) were included in the Vac-SAT group, 98 (12.1%) in the Cov-SAT group, and 455 (56.1%) in the Cont-SAT group. No difference was found between the groups with regard to laboratory and imaging findings. SAT etiology was not an independent predictor of recurrence or hypothyroidism. In the entire cohort, steroid therapy requirement and younger age were statistically significant predictors for SAT recurrence. C-reactive protein measured during SAT onset, female sex, absence of antithyroid peroxidase (TPO) positivity, and absence of steroid therapy were statistically significant predictors of incident (early) hypothyroidism, irrespective of SAT etiology. On the other hand, probable predictors of established hypothyroidism differed from that of incident hypothyroidism.
CONCLUSION: Since there is no difference in terms of follow-up parameters and outcomes, COVID-19- and SARS-CoV-2 vaccine-related SAT can be treated and followed up like classic SATs. Recurrence was determined by younger age and steroid therapy requirement. Steroid therapy independently predicts incident hypothyroidism that may sometimes be transient in overall SAT and is also associated with a lower risk of established hypothyroidism.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:108 |
|---|---|
| Enthalten in: |
The Journal of clinical endocrinology and metabolism - 108(2023), 10 vom: 18. Sept., Seite e1013-e1026 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Batman, Adnan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 19.09.2023 Date Revised 21.09.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1210/clinem/dgad235 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM356889424 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM356889424 | ||
| 003 | DE-627 | ||
| 005 | 20231226071422.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1210/clinem/dgad235 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1189.xml |
| 035 | |a (DE-627)NLM356889424 | ||
| 035 | |a (NLM)37186260 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Batman, Adnan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study) |b A Multicenter Nationwide Study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.09.2023 | ||
| 500 | |a Date Revised 21.09.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com. | ||
| 520 | |a CONTEXT: The aims of the study are to compare characteristics of subacute thyroiditis (SAT) related to different etiologies, and to identify predictors of recurrence of SAT and incident hypothyroidism | ||
| 520 | |a METHODS: This nationwide, multicenter, retrospective cohort study included 53 endocrinology centers in Turkey. The study participants were divided into either COVID-19-related SAT (Cov-SAT), SARS-CoV-2 vaccine-related SAT (Vac-SAT), or control SAT (Cont-SAT) groups | ||
| 520 | |a RESULTS: Of the 811 patients, 258 (31.8%) were included in the Vac-SAT group, 98 (12.1%) in the Cov-SAT group, and 455 (56.1%) in the Cont-SAT group. No difference was found between the groups with regard to laboratory and imaging findings. SAT etiology was not an independent predictor of recurrence or hypothyroidism. In the entire cohort, steroid therapy requirement and younger age were statistically significant predictors for SAT recurrence. C-reactive protein measured during SAT onset, female sex, absence of antithyroid peroxidase (TPO) positivity, and absence of steroid therapy were statistically significant predictors of incident (early) hypothyroidism, irrespective of SAT etiology. On the other hand, probable predictors of established hypothyroidism differed from that of incident hypothyroidism | ||
| 520 | |a CONCLUSION: Since there is no difference in terms of follow-up parameters and outcomes, COVID-19- and SARS-CoV-2 vaccine-related SAT can be treated and followed up like classic SATs. Recurrence was determined by younger age and steroid therapy requirement. Steroid therapy independently predicts incident hypothyroidism that may sometimes be transient in overall SAT and is also associated with a lower risk of established hypothyroidism | ||
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 vaccine | |
| 650 | 4 | |a subacute thyroiditis | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a Steroids |2 NLM | |
| 700 | 1 | |a Yazıcı, Dilek |e verfasserin |4 aut | |
| 700 | 1 | |a Dikbaş, Oğuz |e verfasserin |4 aut | |
| 700 | 1 | |a Ağbaht, Kemal |e verfasserin |4 aut | |
| 700 | 1 | |a Saygılı, Emre Sedar |e verfasserin |4 aut | |
| 700 | 1 | |a Demirci, İbrahim |e verfasserin |4 aut | |
| 700 | 1 | |a Bursa, Nurbanu |e verfasserin |4 aut | |
| 700 | 1 | |a Ayas, Görkem |e verfasserin |4 aut | |
| 700 | 1 | |a Anıl, Cüneyd |e verfasserin |4 aut | |
| 700 | 1 | |a Cesur, Mustafa |e verfasserin |4 aut | |
| 700 | 1 | |a Korkmaz, Fatma Nur |e verfasserin |4 aut | |
| 700 | 1 | |a Bahçecioglu, Adile Begüm |e verfasserin |4 aut | |
| 700 | 1 | |a Çorapçıoğlu, Demet |e verfasserin |4 aut | |
| 700 | 1 | |a Erdoğan, Murat Faik |e verfasserin |4 aut | |
| 700 | 1 | |a Bostan, Hayri |e verfasserin |4 aut | |
| 700 | 1 | |a Calapkulu, Murat |e verfasserin |4 aut | |
| 700 | 1 | |a Hepşen, Sema |e verfasserin |4 aut | |
| 700 | 1 | |a Uçan, Bekir |e verfasserin |4 aut | |
| 700 | 1 | |a Çakal, Erman |e verfasserin |4 aut | |
| 700 | 1 | |a Güler, Bağdagül Yüksel |e verfasserin |4 aut | |
| 700 | 1 | |a Haymana, Cem |e verfasserin |4 aut | |
| 700 | 1 | |a İpekçi, Süleyman Hilmi |e verfasserin |4 aut | |
| 700 | 1 | |a Aydın, Selami |e verfasserin |4 aut | |
| 700 | 1 | |a Sezer, Havva |e verfasserin |4 aut | |
| 700 | 1 | |a Özışık, Seçil |e verfasserin |4 aut | |
| 700 | 1 | |a Deyneli, Oğuzhan |e verfasserin |4 aut | |
| 700 | 1 | |a Alagöl, Faruk |e verfasserin |4 aut | |
| 700 | 1 | |a Tanakol, Refik |e verfasserin |4 aut | |
| 700 | 1 | |a Eroğlu, Mustafa |e verfasserin |4 aut | |
| 700 | 1 | |a Mutlu, Ümmü |e verfasserin |4 aut | |
| 700 | 1 | |a Hacışahinoğulları, Hülya |e verfasserin |4 aut | |
| 700 | 1 | |a Üzüm, Ayşe Kubat |e verfasserin |4 aut | |
| 700 | 1 | |a Demir, Canan |e verfasserin |4 aut | |
| 700 | 1 | |a Koç, Gönül |e verfasserin |4 aut | |
| 700 | 1 | |a Fırat, Sevde Nur |e verfasserin |4 aut | |
| 700 | 1 | |a Omma, Tülay |e verfasserin |4 aut | |
| 700 | 1 | |a İnce, Nurcan |e verfasserin |4 aut | |
| 700 | 1 | |a Polat, Şefika Burçak |e verfasserin |4 aut | |
| 700 | 1 | |a Topaloğlu, Oya |e verfasserin |4 aut | |
| 700 | 1 | |a Aydın, Cevdet |e verfasserin |4 aut | |
| 700 | 1 | |a Çakır, Bekir |e verfasserin |4 aut | |
| 700 | 1 | |a Bahadır, Çiğdem Tura |e verfasserin |4 aut | |
| 700 | 1 | |a Güven, Mehmet |e verfasserin |4 aut | |
| 700 | 1 | |a Sözen, Mehmet |e verfasserin |4 aut | |
| 700 | 1 | |a Selek, Alev |e verfasserin |4 aut | |
| 700 | 1 | |a Cantürk, Zeynep |e verfasserin |4 aut | |
| 700 | 1 | |a Çetinarslan, Berrin |e verfasserin |4 aut | |
| 700 | 1 | |a Aydemir, Mustafa |e verfasserin |4 aut | |
| 700 | 1 | |a Taşkaldıran, Işılay |e verfasserin |4 aut | |
| 700 | 1 | |a Bozkuş, Yusuf |e verfasserin |4 aut | |
| 700 | 1 | |a İyidir, Özlem Turhan |e verfasserin |4 aut | |
| 700 | 1 | |a Haydardedeoğlu, Filiz Ekşi |e verfasserin |4 aut | |
| 700 | 1 | |a Basmaz, Seda Erem |e verfasserin |4 aut | |
| 700 | 1 | |a Ünal, Mehmet Çağrı |e verfasserin |4 aut | |
| 700 | 1 | |a Demir, Tevfik |e verfasserin |4 aut | |
| 700 | 1 | |a Oğuz, Ayten |e verfasserin |4 aut | |
| 700 | 1 | |a Çelik, Özlem |e verfasserin |4 aut | |
| 700 | 1 | |a Yilmaz, Merve |e verfasserin |4 aut | |
| 700 | 1 | |a Cimsir, Aykut |e verfasserin |4 aut | |
| 700 | 1 | |a Kayıhan, Serdar |e verfasserin |4 aut | |
| 700 | 1 | |a Uc, Ziynet Alphan |e verfasserin |4 aut | |
| 700 | 1 | |a Tekin, Sakin |e verfasserin |4 aut | |
| 700 | 1 | |a Topaloğlu, Ömercan |e verfasserin |4 aut | |
| 700 | 1 | |a Saydam, Başak Özgen |e verfasserin |4 aut | |
| 700 | 1 | |a Ünsal, Yasemin Aydoğan |e verfasserin |4 aut | |
| 700 | 1 | |a Özer, Özge |e verfasserin |4 aut | |
| 700 | 1 | |a Yorulmaz, Göknur |e verfasserin |4 aut | |
| 700 | 1 | |a Uğur, Kader |e verfasserin |4 aut | |
| 700 | 1 | |a Çakır, Sezin Doğan |e verfasserin |4 aut | |
| 700 | 1 | |a Aşık, Mehmet |e verfasserin |4 aut | |
| 700 | 1 | |a Unubol, Mustafa |e verfasserin |4 aut | |
| 700 | 1 | |a Genc, Selin |e verfasserin |4 aut | |
| 700 | 1 | |a Andac, Burak |e verfasserin |4 aut | |
| 700 | 1 | |a Okur, Mine |e verfasserin |4 aut | |
| 700 | 1 | |a Dogan, Ozlem |e verfasserin |4 aut | |
| 700 | 1 | |a Karakiliç, Ersen |e verfasserin |4 aut | |
| 700 | 1 | |a Kocabas, Gokcen Unal |e verfasserin |4 aut | |
| 700 | 1 | |a Kirac, Cem Onur |e verfasserin |4 aut | |
| 700 | 1 | |a Cansu, Güven Barış |e verfasserin |4 aut | |
| 700 | 1 | |a Uygur, Meliha Melin |e verfasserin |4 aut | |
| 700 | 1 | |a Pekkolay, Zafer |e verfasserin |4 aut | |
| 700 | 1 | |a Öztürk, Sadettin |e verfasserin |4 aut | |
| 700 | 1 | |a Güngüneş, Aşkın |e verfasserin |4 aut | |
| 700 | 1 | |a Gürkan, Eren |e verfasserin |4 aut | |
| 700 | 1 | |a Keskin, Lezzan |e verfasserin |4 aut | |
| 700 | 1 | |a Çağlayan, Kenan |e verfasserin |4 aut | |
| 700 | 1 | |a Günay, Yasemin Emur |e verfasserin |4 aut | |
| 700 | 1 | |a İmre, Eren |e verfasserin |4 aut | |
| 700 | 1 | |a Şener, Selcuk Yusuf |e verfasserin |4 aut | |
| 700 | 1 | |a Kalkan, Ahmet Toygar |e verfasserin |4 aut | |
| 700 | 1 | |a Gök, Deniz Engin |e verfasserin |4 aut | |
| 700 | 1 | |a Şahin, Mustafa |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of clinical endocrinology and metabolism |d 1945 |g 108(2023), 10 vom: 18. Sept., Seite e1013-e1026 |w (DE-627)NLM00001821X |x 1945-7197 |7 nnns |
| 773 | 1 | 8 | |g volume:108 |g year:2023 |g number:10 |g day:18 |g month:09 |g pages:e1013-e1026 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1210/clinem/dgad235 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 108 |j 2023 |e 10 |b 18 |c 09 |h e1013-e1026 | ||